Fig. 10

Evaluation of potential effects of HGWD on paclitaxel efficacy in tumor cell lines and a tumor growth model. a–b Tumor cell survival as measured by MTT assay in MDA-MB-231 breast cancer cells (a), and CFPAC-1 pancreatic cancer cells (b) (24 h). c–d Tumor size in nude BALB/c mice injected subcutaneously into the right flank with 4 × 10⁶ CFPAC-1 cells and treated with vehicle, paclitaxel (i.p., 10 mg/kg), paclitaxel associated with HGWD (i.g., 30 g/kg). ^**P < 0.01, ^***P < 0.001 vs. vehicle